The selective downregulation of class I major histocompatibility complex proteins by HIV-1 protects HIV-infected cells from NK cells

George B. Cohen; Rajesh T. Gandhi; Daniel M. Davis; Ofer Mandelboim; Benjamin K. Chen; Jack L. Strominger; David Baltimore

doi:10.1016/S1074-7613(00)80065-5

The selective downregulation of class I major histocompatibility complex proteins by HIV-1 protects HIV-infected cells from NK cells

George B. Cohen, Rajesh T. Gandhi, Daniel M. Davis, Ofer Mandelboim, Benjamin K. Chen, Jack L. Strominger, David Baltimore^*

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

763 Scopus citations

Abstract

To avoid detection by CTL, HIV encodes mechanisms for removal of class I MHC proteins from the surface of infected cells. However, class I downregulation potentially exposes the virus-infected cell to attack by NK cells. Human lymphoid cells are protected from NK cell cytotoxicity primarily by HLA-C and HLA-E. We present evidence that HIV-1 selectively downregulates HLA-A and HLA-B but does not significantly affect HLA-C or HLA-E. We then identify the residues in HLA-C and HLA-E that protect them from HIV downregulation. This selective downregulation allows HIV-infected cells to avoid NK cell-mediated lysis and may represent for HIV a balance between escape from CTL and maintenance of protection from NK cells. These results suggest that subpopulations of CTL and NK cells may be uniquely suited for combating HIV.

Original language	English
Pages (from-to)	661-671
Number of pages	11
Journal	Immunity
Volume	10
Issue number	6
DOIs	https://doi.org/10.1016/S1074-7613(00)80065-5
State	Published - Jun 1999
Externally published	Yes

Bibliographical note

Funding Information:
We thank Carlos Lois and members of the Baltimore and Strominger laboratories for helpful discussions, Bruce Walker, Glenn Paradis, Veronique Braud, Eric Long, and Lewis Lanier for reagents and advice on aspects of this project, and Douglas Nixon for communicating unpublished results. G. B. C. was supported by a Merck/Massachusetts Institute of Technology and Helen-Hay Whitney Fellowship, R. T. G. by a Howard Hughes Postdoctoral Research Fellowship for Physicians and a National Institutes of Health Mentored Clinical Scientist Development Award, D. D. by the Irvington Institute, O. M. by the Damon Runyon-Walter Winchell Foundation, B. K. C. by a Medical Scientist Training Program Award, and J. L. S. by National Institutes of Health grant R35CA47554. D. B. is an American Cancer Society Research Professor and was supported at the Massachusetts Institute of Technology by funds from the Ivan R. Cottrell Chair and grants from the National Institutes of Health.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/S1074-7613(00)80065-5

Cite this

@article{f4f1b525f3d0484bbe7638cd4d8da071,

title = "The selective downregulation of class I major histocompatibility complex proteins by HIV-1 protects HIV-infected cells from NK cells",

abstract = "To avoid detection by CTL, HIV encodes mechanisms for removal of class I MHC proteins from the surface of infected cells. However, class I downregulation potentially exposes the virus-infected cell to attack by NK cells. Human lymphoid cells are protected from NK cell cytotoxicity primarily by HLA-C and HLA-E. We present evidence that HIV-1 selectively downregulates HLA-A and HLA-B but does not significantly affect HLA-C or HLA-E. We then identify the residues in HLA-C and HLA-E that protect them from HIV downregulation. This selective downregulation allows HIV-infected cells to avoid NK cell-mediated lysis and may represent for HIV a balance between escape from CTL and maintenance of protection from NK cells. These results suggest that subpopulations of CTL and NK cells may be uniquely suited for combating HIV.",

author = "Cohen, {George B.} and Gandhi, {Rajesh T.} and Davis, {Daniel M.} and Ofer Mandelboim and Chen, {Benjamin K.} and Strominger, {Jack L.} and David Baltimore",

note = "Funding Information: We thank Carlos Lois and members of the Baltimore and Strominger laboratories for helpful discussions, Bruce Walker, Glenn Paradis, Veronique Braud, Eric Long, and Lewis Lanier for reagents and advice on aspects of this project, and Douglas Nixon for communicating unpublished results. G. B. C. was supported by a Merck/Massachusetts Institute of Technology and Helen-Hay Whitney Fellowship, R. T. G. by a Howard Hughes Postdoctoral Research Fellowship for Physicians and a National Institutes of Health Mentored Clinical Scientist Development Award, D. D. by the Irvington Institute, O. M. by the Damon Runyon-Walter Winchell Foundation, B. K. C. by a Medical Scientist Training Program Award, and J. L. S. by National Institutes of Health grant R35CA47554. D. B. is an American Cancer Society Research Professor and was supported at the Massachusetts Institute of Technology by funds from the Ivan R. Cottrell Chair and grants from the National Institutes of Health.",

year = "1999",

month = jun,

doi = "10.1016/S1074-7613(00)80065-5",

language = "אנגלית",

volume = "10",

pages = "661--671",

journal = "Immunity",

issn = "1074-7613",

publisher = "Cell Press",

number = "6",

}

TY - JOUR

T1 - The selective downregulation of class I major histocompatibility complex proteins by HIV-1 protects HIV-infected cells from NK cells

AU - Cohen, George B.

AU - Gandhi, Rajesh T.

AU - Davis, Daniel M.

AU - Mandelboim, Ofer

AU - Chen, Benjamin K.

AU - Strominger, Jack L.

AU - Baltimore, David

N1 - Funding Information: We thank Carlos Lois and members of the Baltimore and Strominger laboratories for helpful discussions, Bruce Walker, Glenn Paradis, Veronique Braud, Eric Long, and Lewis Lanier for reagents and advice on aspects of this project, and Douglas Nixon for communicating unpublished results. G. B. C. was supported by a Merck/Massachusetts Institute of Technology and Helen-Hay Whitney Fellowship, R. T. G. by a Howard Hughes Postdoctoral Research Fellowship for Physicians and a National Institutes of Health Mentored Clinical Scientist Development Award, D. D. by the Irvington Institute, O. M. by the Damon Runyon-Walter Winchell Foundation, B. K. C. by a Medical Scientist Training Program Award, and J. L. S. by National Institutes of Health grant R35CA47554. D. B. is an American Cancer Society Research Professor and was supported at the Massachusetts Institute of Technology by funds from the Ivan R. Cottrell Chair and grants from the National Institutes of Health.

PY - 1999/6

Y1 - 1999/6

N2 - To avoid detection by CTL, HIV encodes mechanisms for removal of class I MHC proteins from the surface of infected cells. However, class I downregulation potentially exposes the virus-infected cell to attack by NK cells. Human lymphoid cells are protected from NK cell cytotoxicity primarily by HLA-C and HLA-E. We present evidence that HIV-1 selectively downregulates HLA-A and HLA-B but does not significantly affect HLA-C or HLA-E. We then identify the residues in HLA-C and HLA-E that protect them from HIV downregulation. This selective downregulation allows HIV-infected cells to avoid NK cell-mediated lysis and may represent for HIV a balance between escape from CTL and maintenance of protection from NK cells. These results suggest that subpopulations of CTL and NK cells may be uniquely suited for combating HIV.

AB - To avoid detection by CTL, HIV encodes mechanisms for removal of class I MHC proteins from the surface of infected cells. However, class I downregulation potentially exposes the virus-infected cell to attack by NK cells. Human lymphoid cells are protected from NK cell cytotoxicity primarily by HLA-C and HLA-E. We present evidence that HIV-1 selectively downregulates HLA-A and HLA-B but does not significantly affect HLA-C or HLA-E. We then identify the residues in HLA-C and HLA-E that protect them from HIV downregulation. This selective downregulation allows HIV-infected cells to avoid NK cell-mediated lysis and may represent for HIV a balance between escape from CTL and maintenance of protection from NK cells. These results suggest that subpopulations of CTL and NK cells may be uniquely suited for combating HIV.

UR - http://www.scopus.com/inward/record.url?scp=0033151621&partnerID=8YFLogxK

U2 - 10.1016/S1074-7613(00)80065-5

DO - 10.1016/S1074-7613(00)80065-5

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???

C2 - 10403641

AN - SCOPUS:0033151621

SN - 1074-7613

VL - 10

SP - 661

EP - 671

JO - Immunity

JF - Immunity

IS - 6

ER -

The selective downregulation of class I major histocompatibility complex proteins by HIV-1 protects HIV-infected cells from NK cells

Abstract

Bibliographical note

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this